Last reviewed · How we verify
NCT06756906
Comparison of High Flow Nasal Oxygen and Nasal Cannula in Burn Patients Under Sedation
trial in Burn Injury in 70 participants. Currently enrolling.
27 January 2025
Quick facts
| Lead sponsor | Ankara City Hospital Bilkent |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 15 July 2024 |
| Primary completion | 27 January 2025 |
| Estimated completion | 10 February 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Burn Injury — all drugs for Burn Injury →
- Hypoxia — all drugs for Hypoxia →
- Sedation — all drugs for Sedation →
Sponsor
Ankara City Hospital Bilkent
Who can join
18 and older, any sex, with Burn Injury or Hypoxia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Burn-related pain is severe and often difficult to manage. Burn patients often require high doses of opioids and anxiolytics. Anesthetic agents used during sedation such as benzodiazepines, propofol and opioids can cause respiratory depression, predisposing patients to hypoventilation and hypoxemia due to airway obstruction. Oxygen is administered to patients with a standard nasal cannula during sedation. High Flow Nasal Oxygen (HFNO) helps to improve the oxygenation of patients with respiratory distress by delivering high flow humidified oxygen through the nasal cannula at a high rate of up to 40-70 liters per minute. The aim of this study was to compare the effects of HFNO and nasal oxygen therapy in preventing hypoxemia in deeply sedated burn patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06756906
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burn Injury
Currently open trials in the same condition.
- NCT07050264 — The Effect of Simulated Burn Injury on Post Exercise Recovery in Hot Environments · NA · recruiting
- NCT06966336 — IEEM- Work:Rest Cycles in Burn Survivors- Humidity · recruiting
- NCT06709781 — Cardiovascular Responses in Burn Survivors During Exercise · NA · recruiting
- NCT05856994 — Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns · Phase 1 · recruiting
- NCT06529757 — Skin Wetting in Burn Survivors · NA · recruiting
Other Ankara City Hospital Bilkent trials
Trials by the same sponsor.
- NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
- NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
- NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
- NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
- NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06756906 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
- Last refreshed: 3 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06756906.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing